Jonathan Winant Carlon, a director of Neptune Insurance Holdings Inc., filed a Form 4 with the SEC on September 15, 2026, disclosing the sale of 50,000 shares of Class A Common Stock on September 14, 2026.

Key Highlights

  • Shares sold: 50,000 shares of Class A Common Stock disposed of on September 14, 2026, with transaction code S.
  • Weighted average price: $31.1519 per share, with individual transactions ranging from $31.15 to $31.37, inclusive.
  • Direct holdings after transaction: 603,500 shares held directly, which includes 73,500 shares underlying time-based restricted stock units.
  • Indirect holdings: 511,000 shares held indirectly via the Carlon Family Trust, dated May 7, 2024, and 4,599,000 shares held indirectly via the JWC Irrevocable Trust.
  • RSU vesting schedule: Restricted stock units vest as to 24,500 shares on September 30, 2026, then 6,125 shares on the last day of each calendar quarter thereafter through September 30, 2028, subject to continuous service.

Carlon's Share Sale and Beneficial Ownership at Neptune Insurance Holdings

According to the filing, Jonathan Winant Carlon, listed as a director of Neptune Insurance Holdings Inc. (NYSE:NP), sold 50,000 shares of Class A Common Stock on September 14, 2026. The reported weighted average price was $31.1519 per share. The filing states that the shares were sold in multiple transactions at prices ranging from $31.15 to $31.37, inclusive, and that full information regarding the number of shares sold at each separate price within that range is available upon request.

Following the reported transaction, the filing discloses that Carlon directly holds 603,500 shares of Class A Common Stock. The filing notes that this figure includes 73,500 shares underlying an award of time-based restricted stock units, as amended. Those units are described as vesting in installments: 24,500 shares on September 30, 2026, and 6,125 shares on the last day of each calendar quarter thereafter through September 30, 2028, in each case subject to the continuous service of the reporting person through the applicable vesting date.

The filing also discloses indirect beneficial ownership of 511,000 shares held by the Carlon Family Trust, dated May 7, 2024, of which Carlon and Alexis Carlon are listed as trustees, and 4,599,000 shares held by the JWC Irrevocable Trust, of which Carlon and Steve Wynne are listed as trustees. No derivative securities transactions were reported in Table II.

What Was Disclosed

The filing reports the sale of 50,000 Class A Common Stock shares by director Jonathan Winant Carlon on September 14, 2026, at a weighted average price of $31.1519, along with his resulting direct and indirect beneficial ownership positions.